Enzon Pharmaceuticals, Inc. (BST:EZ1)

Market Cap	3.78M -61.4%
Revenue (ttm)	n/a
Net Income	-3.14M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	627
Open	0.0445
Previous Close	0.0570
Day's Range	0.0445 - 0.0485
52-Week Range	0.0200 - 0.1200
Beta	n/a
RSI	49.23
Earnings Date	Feb 20, 2026

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: EZ1

Financial Performance

Financial numbers in USD